Definium Therapeutics, Inc. · NASDAQ:DFTX

Barrow Robert sold 29,208 Definium Therapeutics, Inc. shares (Form 4)

Traded Jun 25, 2026 · Filed Jun 26, 2026

On Jun 25, 2026, Barrow Robert (Director, Chief Executive Officer) sold 29,208 Definium Therapeutics, Inc. shares at US$45.03 for US$1.32M under a trading plan, leaving 1,098,246 shares. Filed Jun 26, 2026 (Form 4).

Sold
29,208 shares
Price
US$45.03
Value
US$1.32M
Holding after
1,098,246 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chief Executive Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 25, 2026Common SharesSale29,208US$45.031,098,246Direct

Source

View original at SEC

Related